Piracetam 7491-74-9
Product Description
.cp_wz table {border-top: 1px solid #ccc;border-left:1px solid #ccc; } .cp_wz table td{border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;} .cp_wz table th {border-right: 1px solid #ccc;border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;}
Molecular Weight: 142.16 Piracetam is a cyclic derivative of the neurotransmitter gamma-aminobutyric acid (GABA), used in treatment of a wide range of cognitive disorders.
Biological Activity
Piracetam is able to significantly decrease the fusogenic and
destabilising effect of Abeta 29-42, in a concentration-dependent
manner. Preincubation of piracetam, at a piracetam/peptide ratio of 960,
during 20 min before the addition of Abeta 29-42 prevents almost
completely the mixture of the two fluorescent probes. Preincubation of
piracetam with lipids prevents almost completely the release of calcein
induced by the peptide in a dose-dependent fashion (piracetam/peptide
ratios from 9.6 to 960).
Piracetam (300 mg/kg once daily) significantly increases membrane
fluidity in some brain regions of young and aged rats, but has no
measurable effect on membrane fluidity in the young rats. Piracetam (300 mg/kg daily for 6 weeks) improves active avoidance
learning in the aged rats only and elevates membrane fluidity in all
brain regions except the cerebellum in the aged rats. Piracetam (300
mg/kg daily for 6 weeks) also improves NMDA receptor density in the
hippocampus and on muscarinic cholinergic receptor densities in the
frontal cortex and the striatum and to a lesser extent in the
hippocampus of rats. Piracetam (500 mg/kg p.o. for 14
days) elevates N-methyl-D-aspartate (NMDA) receptor density by about 20%
and normalizes the enhanced affinity of L-glutamate for the NMDA
receptor in aged mice. Piracetam-treated withdrawn rats
has higher the number of synapses than that observed in
nonpiracetam-treated and alcohol-fed animals by up to 20%, the
mechanisms leading to the synaptic reorganization took place at the
mossy fiber level.
Contact us if you need more details on 7491-74-9. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Piracetam 7491-74-9、7491-74-9 Piracetam. If these products fail to match your need, please contact us and we would like to provide relevant information.
Molecular Weight: 142.16 Piracetam is a cyclic derivative of the neurotransmitter gamma-aminobutyric acid (GABA), used in treatment of a wide range of cognitive disorders.
Biological Activity
Piracetam is able to significantly decrease the fusogenic and
destabilising effect of Abeta 29-42, in a concentration-dependent
manner. Preincubation of piracetam, at a piracetam/peptide ratio of 960,
during 20 min before the addition of Abeta 29-42 prevents almost
completely the mixture of the two fluorescent probes. Preincubation of
piracetam with lipids prevents almost completely the release of calcein
induced by the peptide in a dose-dependent fashion (piracetam/peptide
ratios from 9.6 to 960).
Piracetam (300 mg/kg once daily) significantly increases membrane
fluidity in some brain regions of young and aged rats, but has no
measurable effect on membrane fluidity in the young rats. Piracetam (300 mg/kg daily for 6 weeks) improves active avoidance
learning in the aged rats only and elevates membrane fluidity in all
brain regions except the cerebellum in the aged rats. Piracetam (300
mg/kg daily for 6 weeks) also improves NMDA receptor density in the
hippocampus and on muscarinic cholinergic receptor densities in the
frontal cortex and the striatum and to a lesser extent in the
hippocampus of rats. Piracetam (500 mg/kg p.o. for 14
days) elevates N-methyl-D-aspartate (NMDA) receptor density by about 20%
and normalizes the enhanced affinity of L-glutamate for the NMDA
receptor in aged mice. Piracetam-treated withdrawn rats
has higher the number of synapses than that observed in
nonpiracetam-treated and alcohol-fed animals by up to 20%, the
mechanisms leading to the synaptic reorganization took place at the
mossy fiber level.
Contact us if you need more details on 7491-74-9. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Piracetam 7491-74-9、7491-74-9 Piracetam. If these products fail to match your need, please contact us and we would like to provide relevant information.
Product Categories : Neuronal Signaling > GluR Inhibitor
Other Products
Hot Products
Astragaloside AChlortetracycline HCl 64-72-2Paclitaxel 33069-62-4Dexamethasone Acetate 1177-87-3Dinaciclib (SCH727965) 779353-01-4CHIR-124 405168-58-3Ro3280 1062243-51-9TAME 901-47-3CCG-1423 285986-88-110058-F4 403811-55-2Dabigatran (BIBR 953) 211914-51-1H 89 2HCl 130964-39-5T0901317 293754-55-9Aprepitant 170729-80-3Turofexorate Isopropyl (XL335) 629664-81-9BMS-378806 357263-13-9